XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.2
Share-Based Compensation - Weighted average assumptions (Details) - Biostage2013 Equity Incentive Plan [Member]
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Risk-free interest rate 2.59% 0.47%
Expected volatility 124.51% 123.20%
Expected term (years) 5 years 6 months 5 years 3 months 18 days
Expected dividend yield 0.00% 0.00%